Ambrisentan-Mepha 10 mg, Lactab - 30 Swissmedic Key 67294002 Registration Holder Mepha Pharma AG Name Ambrisentan-Mepha 10 mg, Lactab Date of registration 27.10.2020 Original/Generic Generic Introduction of Sequence 27.10.2020 ATC-Classification Ambrisentan (C02KX02) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.10. Show package size 30 Index Therapeuticus (Swissmedic) 02.07.10. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 990.57 Limitation Yes Limitation text
Deductible 10 % Consumer price 1093.70 Feedback FB Daily cost GTIN 7680672940021 Medication Code Synthetika Pharmacode Disponibility
Composition Filmtablette: ambrisentanum 10 mg, lactosum monohydricum 150 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.22 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, macrogolum 3350, lecithinum ex soja, E 171, pro compresso obducto. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose additional_information Ambrisentanum 10 mg Filmtablette
BAG: Active Agent Dose Ambrisentanum 10 mg
Inactive agents Dose additional_information Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. Lactose Monohydrate 150 mg Lecithinum ex Soja Macrogol 3350 Magnesii Stearas Poly(Alcohol Vinylicus) Überzug Pro Compresso Obducto Talcum
Source Data was imported : 07.01.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
